Vincerx Pharma to Participate in the SVB Leerink 11th Annual Global Healthcare Conference

Rhea-AI Summary

PALO ALTO, Calif., Feb. 09, 2022 – Vincerx Pharma, a biopharmaceutical company focused on innovative cancer therapeutics, announced participation in the upcoming SVB Leerink 11th Annual Global Healthcare Conference from February 14-18, 2022. The management team will engage in a fireside chat on February 17, 2022, at 1:40 PM ET. Investors can access the live webcast and archived recordings via Vincerx's website. The company aims to address unmet medical needs with its advanced oncology therapies, including a pipeline developed from an exclusive partnership with Bayer.

PALO ALTO, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that Vincerx’s management team will participate in a fireside chat and one-on-one investor meetings at the SVB Leerink 11^th Annual Global Healthcare Conference, to be held virtually February 14-18, 2022.

Vincerx Fireside Chat Details
Date:	Thursday, February 17, 2022
Time:	1:40 PM Eastern Time
Webcast:	https://wsw.com/webcast/svbleerink67/vinc/2656800

An archived webcast will be accessible in the Investors section of the Company’s website.

About Vincerx Pharma, Inc.

Vincerx Pharma, Inc. (Vincerx) is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. Vincerx has assembled a management team of biopharmaceutical experts with extensive experience in building and operating organizations that develop and deliver innovative medicines to patients. Vincerx’s current pipeline is derived from an exclusive license agreement with Bayer and includes a clinical-stage and follow-on small molecule drug program and a preclinical stage modular bioconjugation platform, which includes next-generation antibody-drug conjugates and innovative small molecule drug conjugates. For more information, please visit www.vincerx.com.

Contact Information

Bruce Mackle
LifeSci Advisors, LLC
646-889-1200
bmackle@lifesciadvisors.com

 

FAQ

What is the purpose of Vincerx's participation in the SVB Leerink Conference?

Vincerx Pharma aims to engage with investors and discuss its advancements in cancer therapeutics.

When will Vincerx Pharma's fireside chat take place?

The fireside chat is scheduled for February 17, 2022, at 1:40 PM Eastern Time.

How can I access the Vincerx Pharma webcast from the conference?

The live webcast can be accessed through Vincerx Pharma's website. An archived version will also be available.

What is Vincerx Pharma's focus in the biopharmaceutical sector?

Vincerx Pharma focuses on developing innovative therapies to meet the unmet medical needs of cancer patients.

Which company is Vincerx Pharma collaborating with for its drug development?

Vincerx Pharma has an exclusive license agreement with Bayer for its pipeline development.